title: Alkylating benzamides with melanoma cytotoxicity.
authors.affiliation: Department of Radiopharmaceutical Chemistry, German Cancer Research Centre Heidelberg and Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Wolf
authors.forename: Ulrike
authors.initials: U
authors.lastname: Bauder-Wüst
authors.forename: Ashour
authors.initials: A
authors.lastname: Mohammed
authors.forename: Frank
authors.initials: F
authors.lastname: Schönsiegel
authors.forename: Walter
authors.initials: W
authors.lastname: Mier
authors.forename: Uwe
authors.initials: U
authors.lastname: Haberkorn
authors.forename: Michael
authors.initials: M
authors.lastname: Eisenhut
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology; D001549:Benzamides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002470:Cell Survival; D002699:Chlorambucil / Q000494:pharmacology; D004396:Coloring Agents / Q000494:pharmacology; D004195:Disease Models, Animal; D016503:Drug Delivery Systems; D015195:Drug Design; D005021:Ethylamines / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D008546:Melanoma, Experimental / Q000188:drug therapy; D051379:Mice; D008956:Models, Chemical; D041681:NIH 3T3 Cells; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011342:Procainamide / Q000494:pharmacology; D013778:Tetrazolium Salts / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D013997:Time Factors; D014018:Tissue Distribution
chemical_list: D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D001549:Benzamides; D004396:Coloring Agents; D005021:Ethylamines; D013778:Tetrazolium Salts; D013844:Thiazoles; D002699:Chlorambucil; C022616:thiazolyl blue; D011342:Procainamide